awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q39367854-2C69DA9E-D219-4B64-84A6-EE88F5883970
Q39367854-2C69DA9E-D219-4B64-84A6-EE88F5883970
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39367854-2C69DA9E-D219-4B64-84A6-EE88F5883970
Off-label use of rituximab for systemic lupus erythematosus in Europe.
P2860
Q39367854-2C69DA9E-D219-4B64-84A6-EE88F5883970
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39367854-2C69DA9E-D219-4B64-84A6-EE88F5883970
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fed9ab762f770c3548b20710ef64c3a72db6c039
P2860
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.